Metlife Inc (MET) concluded trading on Wednesday at a closing price of $68.94, with 4.18 million shares of worth about $288.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 11.28% during that period and on Wednesday the price saw a gain of about 0.47%. Currently the company’s common shares owned by public are about 730.82M shares, out of which, 607.11M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 120 times over the past 12 months. They bought 743,275 shares in 99 of the transactions. In 21 selling transactions, insiders dumped 376,497 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stock saw a price change of 1.62% in past 5 days and over the past one month there was a price change of -0.81%. Year-to-date (YTD), MET shares are showing a performance of 4.25% which decreased to -4.96% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $48.95 but also hit the highest price of $72.71 during that period. The average intraday trading volume for Metlife Inc shares is 3.94 million. The stock is currently trading 0.87% above its 20-day simple moving average (SMA20), while that difference is up 2.11% for SMA50 and it goes to 11.97% higher than SMA200.
Metlife Inc (NYSE: MET) currently have 730.82M outstanding shares and institutions hold larger chunk of about 75.28% of that.
The stock has a current market capitalization of $49.85B and its 3Y-monthly beta is at 1.04. PE ratio of stock for trailing 12 months is 37.68, while it has posted earnings per share of $1.83 in the same period. Its PEG reads 3.28 while making debt-to-equity ratio of 0.65. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MET, volatility over the week remained 1.50% while standing at 1.73% over the month.
Analysts are in expectations that Metlife Inc (MET) stock would likely to be making an EPS of $1.98 in the current quarter, while forecast for next quarter EPS is $2.17 and it is $9.96 for next year. For the current quarter EPS, analysts have given the company a lowest target $1.82 which is $2.1 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $1.52 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 21.26% while it is estimated to increase by 13.06% in next year. EPS is likely to grow at an annualized rate of 11.50% for next 5-years, compared to annual growth of -18.10% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Goldman on January 08, 2024 offering a Buy rating for the stock and assigned a target price of $80 to it. Coverage by Barclays stated Metlife Inc (MET) stock as an Overweight in their note to investors on November 17, 2023, suggesting a price target of $71 for the stock. On October 05, 2023, Deutsche Bank Initiated their recommendations, while on September 14, 2023, Jefferies Upgrade their ratings for the stock with a price target of $72. Stock get a Neutral rating from Goldman on January 09, 2023.
